Wird geladen...
Oral platelet glycoprotein IIb/IIIa receptor inhibitors—part II
Although the hypothesis of benefit from prolonged oral IIb/IIIa inhibition was appealing, the large Phase III trials have uniformly shown there was no improvement in outcome. In addition, there was an increased mortality seen in patients treated with the oral IIb/IIIa inhibitor. This latter finding...
Gespeichert in:
| Veröffentlicht in: | Clin Cardiol |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley Periodicals, Inc.
2006
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654522/ https://ncbi.nlm.nih.gov/pubmed/14524594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960260903 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|